Seattle Genetics Shares Gain 1% April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Jared Haas Seattle Genetics (SGEN) reported its recent studies about the antibody-drug conjugate and related technology.
